YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Image source: The Motley Fool. DATE Thursday, Aug. 13, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Dave Rosa Chief Financial Officer - Chris Volker Chief Business Officer - Dave Wambecke Full Conference Call Transcript…
NeuroOne Medical Technologies Corporation Q3 2026 Earnings Call Summary - Moby Strategic Performance and Operational Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll sh…
NeuroOne Medical Technologies Corporation Q1 2026 Earnings Call Summary - Moby Strategic Execution and Platform Expansion The 1RF brain ablation system saw significant adoption momentum, with nearly half of all historical ablations occurri…
Image source: The Motley Fool. DATE Tuesday, Feb. 17, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer — David A. Rosa Chief Financial Officer — Ronald W. McClurg Need a quote from a Motley Fool analyst? Email pr@fool.com Ful…
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 6: Rigel Pharmaceuticals, Inc. RIGL: This biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate…
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Industrial Logistics Properties Trust ILPT: This real estate investment trust that owns and leases industrial and logistics properties has seen the Zacks Consensus Es…
Veteran Med-Tech Research Analyst & Public Company Executive to Bring Strategic Experience, Industry Relationships and Vision to the Board EDEN PRAIRIE, MINN. - December 22, 2025 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (…
This article first appeared on GuruFocus. Product Revenue: Increased 907% to $2.7 million in Q4 FY2025; 163% to $9.1 million for the full fiscal year 2025. License Revenue: $3 million in fiscal 2025 from the expanded exclusive distribution…
NEW YORK, NY / ACCESS Newswire / September 16, 2025 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day September Small-Cap Conference taking place Wednesday and…
This morning a "Potential Dividend Run Alert" went out for Gilead Sciences Inc (NASD: GILD), at our DividendChannel.com Dividend Alerts service (a free email alerts feature). Let's look at the situation in greater detail, shall we? First o…
NeuroOne Medical Technologies Corporation NMTC recently received FDA 510(k) clearance for its OneRF Trigeminal Nerve Ablation System, a minimally invasive solution for treating severe facial pain. The system delivers targeted radiofrequenc…
FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments EDEN PRAIRIE, Minn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC)…
NeuroOne Medical Technologies(NASDAQ:NMTC) reported fiscal third quarter 2025 earnings on August 14, 2025, with product revenue up 105% year-over-year to $1.7 million and product gross margins rising to 53.9% from 34.1% in the third quarte…
Earnings Call Insights: NeuroOne Medical Technologies Corporation (NMTC) Q3 2025 MANAGEMENT VIEW * CEO David A. Rosa reported "excellent progress in the third quarter of fiscal year 2025 on our financial objectives as well as achieving suc…
NeuroOne Medical Technologies Corp (NASDAQ:NMTC [https://www.chartmill.com/stock/quote/NMTC/profile]) reported its third-quarter fiscal 2025 earnings, delivering mixed results relative to analyst expectations. While revenue growth was stro…
NeuroOne Medical Technologies Corp (NMTC) reported its Q3 2025 earnings, surpassing revenue forecasts with a 9.68% surprise. The company posted a $1.7 million revenue, exceeding the expected $1.55 million. Earnings per share (EPS) improved…
Completed Oversubscribed $8.2 Million Capital Raise; Funded Through At Least Fiscal Year 2026 EDEN PRAIRIE, Minn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a…
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patient…
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patient…
* NeuroOne Medical Technologies (NASDAQ:NMTC [https://seekingalpha.com/symbol/NMTC]) said on Wednesday that it has received a notice of allowance [https://seekingalpha.com/pr/20174982-neuroone-receives-notice-of-allowance-for-key-patent-fr…
EDEN PRAIRIE, Minn. - NeuroOne Medical Technologies Corporation (NASDAQ:NMTC), whose stock has surged over 42% in the past week, has received a notice of allowance from the U.S. Patent and Trademark Office for a patent titled "Methods for…
Patent Strengthens Intellectual Property Portfolio Surrounding Neural Probe Technologies EDEN PRAIRIE, Minn., July 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medic…
EDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patient…
EDEN PRAIRIE, Minn., May 29, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients…
Product Revenue: Increased 97% to $4.7 million for the first six months of fiscal 2025. Product Gross Margin: Increased to 57.9% for the first half of fiscal 2025, more than double from fiscal 2024. License Revenue: $3 million recognized i…
Filed 510(k)Submission with FDA for OneRF®Trigeminal Nerve Ablation System to Treat Facial Pain Ahead of Schedule Company Fully Funded Through at Least Fiscal Year 2026 Following Oversubscribed $8.2 Million Capital Raise EDEN PRAIRIE, Minn…
Significant Neurological Expertise to Help Drive Clinical Development Strategy and Growth with New Technologies EDEN PRAIRIE, Minn., May 12, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or t…
EDEN PRAIRIE, Minn., May 01, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients…
Release Date: January 10, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points NeuroOne Medical Technologies Corp (NASDAQ:NMTC) has three FDA 510(k) cleared electrode fam…
EDEN PRAIRIE, Minn., April 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering f…
EDEN PRAIRIE, Minn., April 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering f…
EDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patien…
NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Today's Marketplace (TMP) is proud to announce a featured interview with NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) CEO Dave Rosa and Jessica Clark, DNP, RN, Dean of the College of…
EDEN PRAIRIE, Minn., March 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patien…
Total Revenue: $6.3 million in Q1 fiscal 2025, a record for NeuroOne. Product Revenue: $3.3 million in Q1 fiscal 2025, up 235% from $1 million in Q1 fiscal 2024. License Revenue: $3 million in Q1 fiscal 2025, from the expanded agreement wi…
EDEN PRAIRIE, Minn., Feb. 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patient…